Open AccessDutasteride in the long-term management of stuttering priapism
Author(s) -
Ryan C. Baker,
Rachel Bergeson,
Ya Sha Yi,
Ellen E. Ward,
Allen F. Morey
Publication year - 2020
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2019.07.15
Subject(s) - dutasteride , medicine , priapism , urology , dosing , erectile dysfunction , pediatrics , surgery , prostate , cancer
The objective of this study is to review our 12-year experience with the 5-α reductase inhibitor dutasteride as a potential long-term treatment option for stuttering priapism. Dutasteride has a uniquely long half-life of 35 days which offers a theoretical advantage as a chronic therapy for management of stuttering priapism.